Term ends Jan 8, 2036 · Medium confidence
20-year base term ends Jan 8, 2036
Held by Ono Pharmaceutical Co., Ltd.
Filed Oct 29, 2021 as application 17/514,878 · Granted Dec 16, 2025
Base term plus 977 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2016
2036
Clock starts
Jan 8, 2016
Jan 8, 2016
Term ends
Jan 8, 2036
Jan 8, 2036
Granted
Dec 16, 2025
Dec 16, 2025
base term
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
977
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 11,065,226.
0 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 977 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 2 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 8, 2016, when application PCT/JP2016/050446, the earliest non-provisional in its chain, was filed (this one was filed Oct 29, 2021) | Jan 8, 2036 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +977 days, USPTO patent term adjustment record | Sep 11, 2038 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 11,065,226) | capped to Jan 8, 2036 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 2 maintenance fees paid | In force | High confidence |
| Further caveats on record | The record rates this date lower than the steps above account for | Medium confidence overall | Medium confidence |
| Computed term end | The steps above, in order | Jan 8, 2036 | Medium confidence |
This family
| US 10,077,247 | In force Jan 2036 | Jan 2036 |
| US 10,538,502 | In force Jan 2036 | Jan 2036 |
| US 11,192,876 | In force no later than Jan 2036 | no later than Jan 2036 |
| US 12,497,377 | this patent Jan 2036 | Jan 2036 |
4 of 5 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jan 2036
Term ends Jan 8, 2036. Maintenance fees still fall due before then
Note
The 977 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 11,065,226.
Citations
0
later US patents cite this one
Fewer than half of the utility patents granted in 2025 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.